Compare AAPG & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAPG | BATRA |
|---|---|---|
| Founded | 2009 | 1991 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | 2025 | N/A |
| Metric | AAPG | BATRA |
|---|---|---|
| Price | $30.00 | $42.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $48.50 | ★ $58.00 |
| AVG Volume (30 Days) | 5.1K | ★ 54.7K |
| Earning Date | 11-19-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $54,524,554.00 | ★ $723,307,000.00 |
| Revenue This Year | N/A | $12.40 |
| Revenue Next Year | $368.64 | $6.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.62 |
| 52 Week Low | $16.50 | $38.67 |
| 52 Week High | $48.45 | $50.50 |
| Indicator | AAPG | BATRA |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 45.95 |
| Support Level | $30.00 | $42.05 |
| Resistance Level | $33.09 | $43.59 |
| Average True Range (ATR) | 0.83 | 0.57 |
| MACD | 0.14 | 0.05 |
| Stochastic Oscillator | 72.07 | 36.13 |
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.